BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 10347283)

  • 1. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
    Liapis H; Marley EF; Lin Y; Dehner LP
    Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors.
    Dugu L; Hayashida S; Nakahara T; Xie L; Iwashita Y; Liu X; Uchi H; Tateuchi S; Takahara M; Oda Y; Moroi Y; Furue M
    Eur J Dermatol; 2010; 20(5):580-4. PubMed ID: 20610366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.
    Kourea HP; Cordon-Cardo C; Dudas M; Leung D; Woodruff JM
    Am J Pathol; 1999 Dec; 155(6):1885-91. PubMed ID: 10595919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of malignant triton tumors.
    Strauss BL; Gutmann DH; Dehner LP; Hirbe A; Zhu X; Marley EF; Liapis H
    Hum Pathol; 1999 Aug; 30(8):984-8. PubMed ID: 10452514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
    McCarron KF; Goldblum JR
    Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
    Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
    Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.
    Woodruff JM
    Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.
    Hunter S; Weiss S; Ou CY; Jaye D; Young A; Wilcox J; Arbiser JL; Monson D; Goldblum J; Nolen JD; Varma V
    Hum Pathol; 2005 Sep; 36(9):987-93. PubMed ID: 16153462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions.
    Zhou H; Coffin CM; Perkins SL; Tripp SR; Liew M; Viskochil DH
    Am J Surg Pathol; 2003 Oct; 27(10):1337-45. PubMed ID: 14508395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor.
    Shaw CM; Grobmyer SR; Ucar DA; Cance WG; Reith JD; Hochwald SN
    Anticancer Res; 2012 Feb; 32(2):439-43. PubMed ID: 22287730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
    Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
    Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors.
    Lin BT; Weiss LM; Medeiros LJ
    Am J Surg Pathol; 1997 Dec; 21(12):1443-9. PubMed ID: 9414187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 amplification in malignant peripheral nerve sheath tumors correlates with p53 protein expression.
    Wallander ML; Tripp S; Layfield LJ
    Arch Pathol Lab Med; 2012 Jan; 136(1):95-9. PubMed ID: 22208493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
    Brossier NM; Carroll SL
    Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors.
    Blessmann M; Gröbe A; Quaas A; Kaifi JT; Mistakidis G; Bernreuther C; Sauter G; Gros S; Rawnaq T; Friedrich R; Mautner VF; Smeets R; Heiland M; Schachner M; Izbicki JR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):239-44. PubMed ID: 22677742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
    Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
    J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.